NEW YORK, N.Y., Oct. 14, 2013 (SEND2PRESS NEWSWIRE) — Blue Horizon International (BHI) participated in the Oman Healthcare Conference and Expo, held September 23 – 25, 2013 at the Oman International Exhibition Centre. As a featured conference presenter and participant in the expo, BHI demonstrated their expertise in stem cell treatments and the potential benefits that regenerative medicine hold for healthcare in Oman, as well as globally.
BHI’s presence at the three day event began with a booth space at the Oman Expo. Their booth provided general information about their expertise in global healthcare consulting, and the work of their stem cells division, Blue Horizon Stem Cells. Word soon traveled through the expo about their documented success in performing over 2250 stem cell treatments. Their Director of International Relations, Klara Doert, realized additional resources were needed. “Numerous Omani’s came to our booth to inquire about stem cell treatments for all kinds of diseases — all of them had medical files in their hands, so I asked them to return when a BHI physician was present.”
That opportunity to meet with a physician came on day three of the conference, after BHI physicians presented “Facilitating Global Development of Regenerative Medicine and Stem Cell Technology” at the conference.
BHI Chief Medical Officer and Founder, Dr. Brian Mehling commented that there were over 75,000 Omani patients last year that went to other countries for treatment of various diseases, some involved cell-based therapies.
Mehling added that, “In the future, BHI will direct this outbound patient population to our state-of-the-art clinical facilities in Europe and Asia.” Based on the lines that began to form around the BHI booth at the expo, this opportunity could occur reasonably soon.
The response received at the Oman Healthcare Conference and Expo is another example of the excitement and interest that regenerative medicine and stem cell based treatment is creating globally. Blue Horizon International remains at the forefront of this cutting-edge technology and currently operates stem cell treatment facilities in China and Slovakia, to facilitate its clinical research and treatments.
Blue Horizon International is a healthcare consulting company with a unique concept that combines treatment, research and philanthropy. Blue Horizon International provides quality care and service for medical treatments globally, advanced technologies in stem cell therapies, and also provides resources needed to assist children and adults who are medically underserved. For more information please visit Blue Horizon International at http://www.bluehorizoninternational.com/ .
NEWS SOURCE: Blue Horizon International :: This press release was issued on behalf of the news source (who is solely responsible for its accuracy) by Send2Press® Newswire, a service of Neotrope®.
